Christophe Pignier

Title: Christophe Pignier: Innovator in Human Therapy

Introduction

Christophe Pignier is a notable inventor based in Castres, France. He has made significant contributions to the field of human therapy through his innovative work in the development of pharmaceutical compounds. With a total of three patents to his name, Pignier's inventions focus on the treatment of various medical conditions.

Latest Patents

Pignier's latest patents include "Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy." This invention concerns derivatives of heteroarylsulfonamides, which act as blockers of Kv potassium channels, specifically Kv1.5, Kv4.3, and Kv11.1. The compounds are designed for clinical therapy and include various substituents that enhance their efficacy. Another significant patent is "Diarylpyridazinone derivatives, preparation thereof, and use thereof for the treatment of humans." This invention also targets Kv channels and outlines the preparation and application of these compounds in medical treatments.

Career Highlights

Throughout his career, Christophe Pignier has worked with prominent companies such as Pierre Fabre Medicament and Pierre Fabre Médicament. His work in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Pignier has collaborated with esteemed colleagues, including Elisabeth Dupont-Passelaigue and Isabelle Le Roy. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Christophe Pignier is a distinguished inventor whose work in the field of human therapy has led to the development of valuable pharmaceutical compounds. His contributions continue to impact the medical community positively.